Assessment of malignancy risk in patients with multiple sclerosis treated with intramuscular interferon beta-1a: retrospective evaluation using a health insurance claims database and postmarketing surveillance data
2017 ◽
Vol 6
(1)
◽
pp. 91-102
◽
Aaron Boster
◽
Jacqueline Nicholas
◽
Ning Wu
◽
Wei-Shi Yeh
◽
Monica Fay
◽
...
2017 ◽
Vol 8
(4)
◽
pp. 318-326
◽
Mieko Ogino
◽
Shuichi Okamoto
◽
Hiroyuki Ohta
◽
Mariko Sakamoto
◽
Yusuke Nakamura
◽
...
Misuzu Sato
◽
Hayato Yamana
◽
Sachiko Ono
◽
Miho Ishimaru
◽
Hiroki Matsui
◽
...
2013 ◽
Vol 03
(04)
◽
pp. 311-316
◽
Masayoshi Miura
◽
Keiko Sato
◽
Hisao Muto
◽
Kusuma Gopala
◽
Katsiaryna Holl
2013 ◽
Vol 16
(7)
◽
pp. A558
Y.J. Kim
◽
J.H. Ahn
◽
E.J. Jang
◽
Y.J. Jung
◽
J.J. Yoo
◽
...
2013 ◽
Vol 67
(2)
◽
pp. 294-298
◽
Chung Am Choi
◽
Min Jung Chang
◽
Hye Duck Choi
◽
Woo-Young Chung
◽
Wan Gyoon Shin
2019 ◽
Vol 47
(6)
◽
pp. 513-519
◽
Munkhzul Radnaabaatar
◽
Young‐Eun Kim
◽
Dun‐Sol Go
◽
Yunsun Jung
◽
Jaehun Jung
◽
...
H. Eichler
◽
F. Langer
◽
J. Koscielny
◽
D. Beier
◽
N. Schmedt
◽
...
2020 ◽
Vol Volume 12
◽
pp. 1007-1013
Meng-Tsang Hsieh
◽
Cheng-Yang Hsieh
◽
Tzu-Tung Tsai
◽
Yi-Ching Wang
◽
Sheng-Feng Sung
2018 ◽
Vol 21
◽
pp. S166-S167
Close
Export Citation Format
Close
Share Document
Close